Crinetics Pharmaceuticals
(NASDAQ) CRNX
Crinetics Pharmaceuticals Financials at a Glance
Market Cap
$3.90B
Revenue (TTM)
$5.42M
Net Income (TTM)
$465.32M
EPS (TTM)
$-4.94
P/E Ratio
-7.53
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$37.20
Volume
52,734
Open
$36.35
Price
$37.20
Volume
52,734
Open
$36.35
Previous Close
$37.20
Daily Range
$35.90 - $37.21
52-Week Range
$24.10 - $57.99
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$37.20
Volume
52,734
Open
$36.35
Previous Close
$37.20
Daily Range
$35.90 - $37.21
52-Week Range
$24.10 - $57.99
CRNX News
CRNX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Crinetics Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
594
CEO
Scott R. Struthers, PhD
Website
www.crinetics.comHeadquarters
San Diego, CA 92121, US
CRNX Financials
Key Financial Metrics (TTM)
Gross Margin
1%
Operating Margin
-95%
Net Income Margin
-86%
Return on Equity
-40%
Return on Capital
-49%
Return on Assets
-41%
Earnings Yield
-13.28%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.90B
Shares Outstanding
104.70M
Volume
52.73K
Short Interest
0.00%
Avg. Volume
1.29M
Financials (TTM)
Gross Profit
$2.73M
Operating Income
$516.77M
EBITDA
$461.25M
Operating Cash Flow
$377.92M
Capital Expenditure
$5.76M
Free Cash Flow
$383.68M
Cash & ST Invst.
$1.03B
Total Debt
$48.54M
Crinetics Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.88M
N/A
Gross Profit
$4.34M
N/A
Gross Margin
1.12%
N/A
Market Cap
$3.90B
N/A
Market Cap/Employee
$8.92M
N/A
Employees
437
N/A
Net Income
$122.81M
-52.4%
EBITDA
$121.64M
-29.5%
Quarterly Fundamentals
Net Cash
$979.35M
-24.8%
Accounts Receivable
$592.00K
-93.0%
Inventory
$2.02M
N/A
Long Term Debt
$42.05M
-5.6%
Short Term Debt
$6.49M
-9.3%
Return on Assets
-40.98%
N/A
Return on Invested Capital
-49.20%
N/A
Free Cash Flow
$93.36M
-42.1%
Operating Cash Flow
$92.90M
-43.6%